Frank Schilling beats $200 billion healthcare giant Novartis in UDRP
9 year delay in filing UDRP hurts pharma company’s claim of disruption to its business.
Frank Schilling has successfully defended the domain name ClearCare.com in a UDRP filed by Novartis AG.
Novartis, which has a $200 billion market cap, offers a line of contact lens cleaning solutions under the name Clear Care.
Schilling (through attorney John Berryhill) noted that his business involves registering expired domain names and parking them with ad links unrelated to any trademark usage. ClearCare.com was parked with links related to “care” but not contact lenses.
This helped Schilling win the rights/legitimate interest issue.
The doctrine of laches played a big role in the case as well. Schilling registered the domain in 2005 and Novartis just came after it in 2014. The panel noted:
Complainant cannot credibly claim that its business has been seriously disrupted by the clearcare.com domain name or the resolving webpage, because Respondent has been using the disputed domain name for nine years prior to Complainant’s bringing this action.